Provided by Tiger Fintech (Singapore) Pte. Ltd.

Park Hotels & Resorts Inc.

10.85
+0.24502.31%
Volume:797.97K
Turnover:8.61M
Market Cap:2.17B
PE:17.80
High:10.93
Open:10.66
Low:10.63
Close:10.60
Loading ...

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress

GlobeNewswire
·
Yesterday

Press Release: Agios Appoints Dr. Jay Backstrom to Board of Directors

Dow Jones
·
Yesterday

Park Hotels & Resorts Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
01 Jul

Analysts Conflicted on These Real Estate Names: RLJ Lodging (RLJ), Park Hotels & Resorts (PK) and Essex Property (ESS)

TIPRANKS
·
01 Jul

Park Hotels & Resorts Initiated at Underweight by JP Morgan

Dow Jones
·
23 Jun

Pulmovant announces publication of PK, lung deposition data for mosliciguat

TIPRANKS
·
16 Jun

Park Hotels & Resorts Inc. Announces Second Quarter 2025 Earnings Release

Reuters
·
10 Jun

Sunstone Hotel Investors Completes Sale of Hilton New Orleans St. Charles, Reinvests Proceeds in Share Repurchases

Reuters
·
09 Jun

Neurotech International’s NTI164 Shows Promising PK Study Results

TIPRANKS
·
02 Jun

Park Hotels & Resorts Cut to Hold From Buy by Truist Securities

Dow Jones
·
31 May

Truist Financial downgrades Park Hotels & Resorts (PK) to a Hold

TIPRANKS
·
30 May

Truist Downgrades Park Hotels & Resorts to Hold From Buy, Cuts Price Target to $11 From $16

MT Newswires Live
·
30 May

BRIEF-Park Hotels & Resorts Inc. Announces Sale Of Hyatt Centric Fisherman’S Wharf

Reuters
·
23 May

Park Hotels & Resorts Inc. Sells Hyatt Centric Fisherman's Wharf for $80 Million to Enhance Portfolio and Liquidity

Reuters
·
23 May

Park Hotels & Resorts Inc. Announces Sale of Hyatt Centric Fisherman’s Wharf

THOMSON REUTERS
·
23 May

Park Hotels & Resorts Cut to In-Line From Outperform by Evercore ISI Group

Dow Jones
·
17 May

Press Release: Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Dow Jones
·
15 May

Press Release: Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
15 May

Press Release: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Dow Jones
·
14 May

Press Release: Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

Dow Jones
·
13 May